Duvoisin Gilles, Fischer Céline, Maucort-Boulch Delphine, Giannoni Eric
Service of Neonatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;
Service of Neonatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Service of Neonatology, Hôpital Femme Mère Enfants, Hospices Civils de Lyon, Bron, France.
Swiss Med Wkly. 2014 Jun 25;144:w13981. doi: 10.4414/smw.2014.13981. eCollection 2014.
Despite a low positive predictive value, diagnostic tests such as complete blood count (CBC) and C-reactive protein (CRP) are commonly used to evaluate whether infants with risk factors for early-onset neonatal sepsis (EOS) should be treated with antibiotics.
We investigated the impact of implementing a protocol aiming at reducing the number of diagnostic tests in infants with risk factors for EOS in order to compare the diagnostic performance of repeated clinical examination with CBC and CRP measurement. The primary outcome was the time between birth and the first dose of antibiotics in infants treated for suspected EOS.
Among the 11,503 infants born at ≥35 weeks during the study period, 222 were treated with antibiotics for suspected EOS. The proportion of infants receiving antibiotics for suspected EOS was 2.1% and 1.7% before and after the change of protocol (p = 0.09). Reduction of diagnostic tests was associated with earlier antibiotic treatment in infants treated for suspected EOS (hazard ratio 1.58; 95% confidence interval [CI] 1.20-2.07; p <0.001), and in infants with neonatal infection (hazard ratio 2.20; 95% CI 1.19-4.06; p = 0.01). There was no difference in the duration of hospital stay nor in the proportion of infants requiring respiratory or cardiovascular support before and after the change of protocol.
Reduction of diagnostic tests such as CBC and CRP does not delay initiation of antibiotic treatment in infants with suspected EOS. The importance of clinical examination in infants with risk factors for EOS should be emphasised.
尽管阳性预测值较低,但全血细胞计数(CBC)和C反应蛋白(CRP)等诊断测试仍常用于评估有早发型新生儿败血症(EOS)风险因素的婴儿是否应接受抗生素治疗。
我们调查了实施一项旨在减少有EOS风险因素婴儿诊断测试数量的方案的影响,以比较重复临床检查与CBC和CRP测量的诊断性能。主要结局是疑似EOS接受治疗的婴儿从出生到首次使用抗生素的时间。
在研究期间出生的11,503名孕周≥35周的婴儿中,222名因疑似EOS接受了抗生素治疗。方案改变前后,因疑似EOS接受抗生素治疗的婴儿比例分别为2.1%和1.7%(p = 0.09)。减少诊断测试与疑似EOS接受治疗的婴儿更早接受抗生素治疗相关(风险比1.58;95%置信区间[CI] 1.20 - 2.07;p <0.001),在新生儿感染的婴儿中也是如此(风险比2.20;95% CI 1.19 - 4.06;p = 0.01)。方案改变前后,住院时间以及需要呼吸或心血管支持的婴儿比例没有差异。
减少CBC和CRP等诊断测试不会延迟疑似EOS婴儿抗生素治疗的开始。应强调临床检查在有EOS风险因素婴儿中的重要性。